ERBB2 and breast cancer: Similar to the effects of HER2 and STAT3 inhibition, survivin depletion increased radiation-induced cell death and reduced clonogenic survival of HER2-positive SKBR3 breast cancer cells (Figure 4D and E), but it did not affect HER2 and STAT3 phosphorylation (Figure 4D).